Skip to main content
. 2023 Jul 8;5(1):vdad083. doi: 10.1093/noajnl/vdad083

Table 3.

Patients Eligible for a Trial at Different Cutpoints for Hematologic Parameters at Time of First Recurrence

Recurrent Patients Eligible Per Hematologic Criteria (%, n)
Lymphocyte > 0.25 94% (442/468)
Lymphocyte > 0.5 72% (336/468)
Lymphocyte > 0.75 44% (205/468)
Lymphocyte > 1 25% (118/468)
Neutrophil > 0.5 99.8% (452/453)
Neutrophil > 1 99% (449/453)
Neutrophil > 1.5 98% (444/453)
Neutrophil > 2 87% (393/453)
PLT > 50 99% (450/456)
PLT > 75 96% (438/456)
PLT > 100 87% (396/456)
PLT > 150 58% (265/456)